High impact
76
supply_energy / systemic issueearnings
Source
Systemic monitor
Decided
2026-05-01
AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline
ANTX
AN2 TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Curated Events
1
Active
Recent Headlines
0
New
Recent news sentiment
+0.1
30-day score
Company
-
30-day
Macro
-
30-day
Pulse
-
30-day
Curated events
Sentiment decomposition
+0.1
30-day score
Company-55%
Macro-30%
Pulse-15%
The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.
Recent headlines
No supplemental ticker headlines stored yet
We are still collecting relevant articles for ANTX. Curated events highlight the most material developments impacting this ticker right now.
As of 2026-05-01 • Updated scheduledSource: News desk